EXFY vs. DCBO, SCWX, RDVT, VMEO, ECX, CGNT, RCAT, NEXN, WEAV, and SMWB
Should you be buying Expensify stock or one of its competitors? The main competitors of Expensify include Docebo (DCBO), SecureWorks (SCWX), Red Violet (RDVT), Vimeo (VMEO), ECARX (ECX), Cognyte Software (CGNT), Red Cat (RCAT), Nexxen International (NEXN), Weave Communications (WEAV), and Similarweb (SMWB). These companies are all part of the "computer software" industry.
Expensify vs. Its Competitors
Docebo (NASDAQ:DCBO) and Expensify (NASDAQ:EXFY) are both small-cap computer software companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, media sentiment and profitability.
Docebo presently has a consensus price target of $44.13, suggesting a potential upside of 49.93%. Expensify has a consensus price target of $4.00, suggesting a potential upside of 59.05%. Given Expensify's higher possible upside, analysts plainly believe Expensify is more favorable than Docebo.
Docebo has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500. Comparatively, Expensify has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500.
53.2% of Docebo shares are held by institutional investors. Comparatively, 68.4% of Expensify shares are held by institutional investors. 12.3% of Expensify shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Expensify had 2 more articles in the media than Docebo. MarketBeat recorded 5 mentions for Expensify and 3 mentions for Docebo. Docebo's average media sentiment score of 0.43 beat Expensify's score of 0.36 indicating that Docebo is being referred to more favorably in the media.
Docebo has a net margin of 10.34% compared to Expensify's net margin of -6.66%. Docebo's return on equity of 55.63% beat Expensify's return on equity.
Docebo has higher revenue and earnings than Expensify. Expensify is trading at a lower price-to-earnings ratio than Docebo, indicating that it is currently the more affordable of the two stocks.
Summary
Docebo beats Expensify on 10 of the 15 factors compared between the two stocks.
Get Expensify News Delivered to You Automatically
Sign up to receive the latest news and ratings for EXFY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EXFY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Expensify Competitors List
Related Companies and Tools
This page (NASDAQ:EXFY) was last updated on 7/6/2025 by MarketBeat.com Staff
Free EXFY Stock Alerts